MARKET

TFX

TFX

Teleflex Inc
NYSE

Real-time Quotes | Nasdaq Last Sale

288.36
+2.89
+1.01%
Opening 13:52 05/27 EDT
OPEN
287.30
PREV CLOSE
285.47
HIGH
289.13
LOW
285.90
VOLUME
96.96K
TURNOVER
15.14M
52 WEEK HIGH
428.36
52 WEEK LOW
256.45
MARKET CAP
13.52B
P/E (TTM)
28.05
1D
5D
1M
3M
1Y
5Y
RBC Capital Sees Meaningful M&A Execution For This Critical Care-Focused Stock
Teleflex Inc (NYSE: TFX) hosted its Investor Day and issued plans for 2023-2025. RBC Capital Markets believe TFX is a stronger company delivering stable revenue growth in the M-HSDs, margin expansion, double-digit EPS growth, and strong FCF. 
Benzinga · 4d ago
Expert Ratings for Teleflex
Over the past 3 months, 12 analysts have published their opinion on Teleflex (NYSE:TFX) stock. These analysts are typically employed by large Wall Street banks and tasked with understanding a company's business to predict how a stock will trade over the up...
Benzinga · 4d ago
Truist Securities Adjusts Teleflex's Price Target to $317 from $340, Keeps Hold Rating
MT Newswires · 5d ago
Raymond James Adjusts Price Target for Teleflex to $325 From $355, Maintains Outperform Rating
MT Newswires · 5d ago
RBC Cuts Price Target on Teleflex to $380 From $390, Maintains Outperform Rating
MT Newswires · 5d ago
BRIEF-Teleflex Inc - Reaffirms Its Previously Provided Financial Guidance For 2022
reuters.com · 05/20 13:32
Teleflex Reaffirms FY22 Guidance Ahead Of Friday Investor Day; Event Begins At 10 a.m. EDT
Teleflex Incorporated (NYSE:TFX), a leading global provider of medical devices, will provide an update on its business and address its 2023-2025 business growth strategy and financial goals during its 2022 Analyst &
Benzinga · 05/20 10:35
Teleflex Hosts 2022 Analyst & Investor Day
WAYNE, Pa., May 20, 2022 (GLOBE NEWSWIRE) -- Teleflex Incorporated (NYSE: TFX), a leading global provider of medical devices, will provide an update on its business and address its 2023-2025 business growth strategy and financial goals during its 2022 Anal...
GlobeNewswire · 05/20 10:30
More
No Data
Learn about the latest financial forecast of TFX. Analyze the recent business situations of Teleflex Inc through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 12 analysts

Buy

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

8.33%Strong Buy
41.67%Buy
50.00%Hold
0.00%Under-perform
0.00%Sell
Analyst Price Target
The average TFX stock price target is 352.80 with a high estimate of 430.00 and a low estimate of 295.00.
High430.00
Average352.80
Low295.00
Current 290.09
EPS
Actual
Estimate
0.901.802.703.60
Q2 2021
Q3 2021
Q4 2021
Q1 2022
Q2 2022
Institutional Holdings
Institutions: 738
Institutional Holdings: 49.15M
% Owned: 104.79%
Shares Outstanding: 46.90M
TypeInstitutionsShares
Increased
180
2.36M
New
70
452.25K
Decreased
187
2.41M
Sold Out
64
926.30K
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Medical Equipment, Supplies & Distribution
+1.86%
Healthcare Equipment & Supplies
+2.75%
Key Executives
Chairman/President/Chief Executive Officer/Director
Liam Kelly
Chief Financial Officer/Executive Vice President
Thomas Powell
Vice President/General Counsel/Secretary
Daniel Logue
Vice President/Director of Human Resources
Cameron Hicks
Vice President
Jay White
Vice President
James Winters
Lead Director/Independent Director
George Babich
Independent Director
Candace Duncan
Independent Director
Gretchen Haggerty
Independent Director
John Heinmiller
Independent Director
Stephen Klasko
Independent Director
Andrew Krakauer
Independent Director
Stuart Randle
No Data
No Data
About TFX
Teleflex Incorporated is a provider of medical technology products. The Company primarily designs, develops, manufactures and supplies single-use medical devices used by hospitals and healthcare providers for common diagnostic and therapeutic procedures in critical care and surgical applications. The Company operates through four segments: Americas; Europe, Middle East and Africa (EMEA); Asia (Asia Pacific), and Original Equipment Manufacturer and Development Services (OEM). Its product categories include vascular access, anesthesia, interventional, surgical, interventional urology, and urology. The Company's specialty product line of urology products provides bladder management. The product portfolio consists of a range of catheters, including Foley, intermittent, external and suprapubic; urine collectors; catheterization accessories, and products for operative endourology marketed under the Rusch brand name.

Webull offers kinds of Teleflex Incorporated stock information, including NYSE:TFX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, TFX stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading TFX stock methods without spending real money on the virtual paper trading platform.